The short-term safety and efficacy of fluoxetine in depressed adolescents with alcohol and cannabis use disorders: a pilot randomized placebo-controlled trial

scientific article published on 19 March 2009

The short-term safety and efficacy of fluoxetine in depressed adolescents with alcohol and cannabis use disorders: a pilot randomized placebo-controlled trial is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1049497826
P356DOI10.1186/1753-2000-3-11
P932PMC publication ID2666637
P698PubMed publication ID19298659
P5875ResearchGate publication ID24212549

P50authorMaria PaganoQ47808260
Robert L FindlingQ90314248
Christine A DemeterQ105682824
P2093author name stringMichael D Reed
Jacqui Lingler
Nora K McNamara
Robert J Stansbrey
Denise Bedoya
Jon E Faber
P2860cites workEfficacy of antidepressants in juvenile depression: meta-analysisQ22255557
An Inventory for Measuring DepressionQ26778503
A children's global assessment scale (CGAS)Q28271291
Hopelessness and eventual suicide: a 10-year prospective study of patients hospitalized with suicidal ideationQ28307938
Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity dataQ29616031
The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trialsQ29619671
The use of antidepressants to treat depression in children and adolescentsQ34257369
Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trialQ34341755
Adolescent psychopathology: I. Prevalence and incidence of depression and other DSM-III-R disorders in high school studentsQ34360713
Childhood and adolescent depression: a review of the past 10 years. Part I.Q34736609
Course and outcome of child and adolescent major depressive disorderQ34834286
The relevance of pharmacokinetic studies in designing efficacy trials in juvenile major depressionQ36428441
The B-Value: A Tool for Monitoring DataQ36453425
Psychosocial risk factors for future adolescent suicide attemptsQ41036796
The Cannabis Youth Treatment (CYT) Study: main findings from two randomized trialsQ42638750
Fluoxetine in adolescents with major depression and an alcohol use disorder: an open-label trialQ42662291
Fluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled, randomized clinical trialQ44168453
Characteristics of suicide attempters in a population-based sample of Dutch adolescentsQ44594867
Common problems and coping strategies. II: Findings with adolescent suicide attemptersQ45764098
A randomized controlled trial of fluoxetine and cognitive behavioral therapy in adolescents with major depression, behavior problems, and substance use disordersQ46913407
Suicidality in pediatric patients treated with antidepressant drugsQ46977975
Hopelessness and suicidal ideation among adolescents in two culturesQ47281715
Relationship between hopelessness and ultimate suicide: a replication with psychiatric outpatientsQ47355076
The measurement of pessimism: the hopelessness scale.Q47359395
Unipolar depression in adolescents: clinical outcome in adulthoodQ48820908
Psychological autopsy of completed suicide in children and adolescentsQ49201340
A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression.Q50924850
Age- and sex-related risk factors for adolescent suicide.Q51979337
Incidence of major depressive disorder and dysthymia in young adolescents.Q52002650
Addiction-risk behaviours and suicide attempts in adolescents.Q52276001
Fluoxetine in drug-dependent delinquents with major depression: an open trial.Q53966884
Suicidal behaviors and childhood-onset depressive disorders: a longitudinal investigationQ70550378
Dysthymia characteristic of heavy alcohol use in depressed adolescentsQ70597395
Fluoxetine in depressed alcoholics. A double-blind, placebo-controlled trialQ73665552
A double-blind, placebo-controlled trial of sertraline in depressed adolescent alcoholics: a pilot studyQ78439763
P275copyright licenseCreative Commons Attribution 2.0 GenericQ19125117
P6216copyright statuscopyrightedQ50423863
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectplaceboQ269829
fluoxetineQ422244
teenagerQ1492760
placebo-controlled trialQ108853737
P304page(s)11
P577publication date2009-03-19
P1433published inChild and Adolescent Psychiatry and Mental HealthQ15767228
P1476titleThe short-term safety and efficacy of fluoxetine in depressed adolescents with alcohol and cannabis use disorders: a pilot randomized placebo-controlled trial
P478volume3

Reverse relations

cites work (P2860)
Q36530819A preliminary examination of how serotonergic polymorphisms influence brain response following an adolescent cannabis intervention
Q34124607Do Hospital and Community SSRI Usage Patterns in Children and Adolescents Match the Evidence?
Q38602146Efficacy and Safety of Selective Serotonin Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors, and Placebo for Common Psychiatric Disorders Among Children and Adolescents: A Systematic Review and Meta-analysis.
Q38237466Efficacy and tolerability of antidepressants in the treatment of adolescents and young adults with depression and substance use disorders: a systematic review and meta-analysis
Q35878089Evaluation of a spirituality informed e-mental health tool as an intervention for major depressive disorder in adolescents and young adults - a randomized controlled pilot trial
Q47582630Generalizability of Clinical Trial Results for Adolescent Major Depressive Disorder
Q35582292Generalizability of clinical trials for cannabis dependence to community samples
Q36151947Moderators of fluoxetine treatment response for children and adolescents with comorbid depression and substance use disorders
Q24202873Newer generation antidepressants for depressive disorders in children and adolescents
Q24187250Pharmacotherapies for cannabis dependence
Q61440575Pharmacotherapies for cannabis dependence
Q37574339Pharmacotherapy for Substance Use Disorders in Youths
Q90393501Placebo response rates and potential modifiers in double-blind randomized controlled trials of second and newer generation antidepressants for major depressive disorder in children and adolescents: a systematic review and meta-regression analysis
Q37417696Using Bayes factors for testing hypotheses about intervention effectiveness in addictions research